Clinical Trials Browser

Phase 3 × Completed × Basal Cell Nevus Syndrome × Clear all

NCT03703310 2024-07-03

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Phase 3 Completed

174 enrolled 23 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell